Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Industry, Sector and Symbol:

Sector: Medical
Industry: Managed Health Care - NEC
Sub-Industry: Managed Health Care
Symbol: NYSE:HUM
CUSIP: 44485910
Web: www.humana.com

Capitalization:

Market Cap: $34.05 billion
Outstanding Shares: 144,315,000

Average Prices:

50 Day Moving Avg: $235.90
200 Day Moving Avg: $218.69
52 Week Range: $163.50 - $243.74

P/E:

Trailing P/E Ratio: 24.00
Foreward P/E Ratio: 19.37
P/E Growth: 1.63

Sales & Book Value:

Annual Revenue: $54.34 billion
Price / Sales: 0.63
Book Value: $70.91 per share
Price / Book: 3.33

Dividend:

Annual Dividend: $1.60
Dividend Yield: 0.6%

Profitability:

EBIDTA: $2.27 billion
Net Margins: 2.71%
Return on Equity: 14.38%
Return on Assets: 5.44%

Debt:

Debt-to-Equity Ratio: 0.47%
Current Ratio: 1.65%
Quick Ratio: 1.65%

Misc:

Average Volume: 1.47 million shs.
Beta: 0.91
Short Ratio: 3.51

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 20th. Investors of record on Friday, June 30th will be given a dividend of $0.40 per share on Monday, July 31st. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date is Wednesday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its Board of Directors has approved a share buyback plan on Tuesday, April 11th 2017, which allows the company to repurchase $2,250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 7.3% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) posted its quarterly earnings results on Wednesday, May, 3rd. The company reported $2.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.55 by $0.20. The firm earned $13.76 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 2.71% and a return on equity of 14.38%. During the same quarter in the prior year, the company posted $1.86 earnings per share. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $11.10+ for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.15.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

20 brokerages have issued 1-year price objectives for Humana's shares. Their forecasts range from $170.00 to $275.00. On average, they anticipate Humana's stock price to reach $229.50 in the next year. View Analyst Ratings for Humana.

Who are some of Humana's key competitors?

Some companies that are related to Humana include Aetna (AET), Anthem (ANTM), Cigna Corporation (CI), Centene Corporation (CNC), WellCare Health Plans (WCG), Magellan Health (MGLN), Triple-S Management Corporation (GTS), Catamaran Corp (CTRX), Catamaran Corp (SXCI) and Universal American (UAM).

Who are Humana's key executives?

Humana's management team includes the folowing people:

Kurt J. Hilzinger, Independent Chairman of the Board
Bruce D. Broussard, President, Chief Executive Officer, Director
Brian A. Kane, Chief Financial Officer, Senior Vice President
Timothy S. Huval, Chief Human Resource Officer, Senior Vice President
Brian P. LeClaire, Senior Vice President, Chief Information Officer
Sam Deshpande, Senior Vice President, Chief Risk Officer
Christopher M. Todoroff, Senior Vice President, General Counsel
Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer
Jody L. Bilney, Senior Vice President, Chief Consumer Officer
Christopher H. Hunter, Senior Vice President, Chief Strategy Officer

Who owns Humana stock?

Humana's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.26%), APG Asset Management N.V. (0.17%), National Pension Service (0.09%), Chevy Chase Trust Holdings Inc. (0.09%), Aperio Group LLC (0.07%) and Hermes Investment Management Ltd. (0.05%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Exxonmobil Investment Management Inc. TX, Chevy Chase Trust Holdings Inc., NN Investment Partners Holdings N.V., State Treasurer State of Michigan, First Quadrant L P CA, Hermes Investment Management Ltd., Central Bank & Trust Co. and Huntington National Bank. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, APG Asset Management N.V., CHURCHILL MANAGEMENT Corp, Meeder Asset Management Inc., Aperio Group LLC, Mn Services Vermogensbeheer B.V., National Pension Service and Nisa Investment Advisors LLC. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $235.92.

MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		482 (Vote Outperform)
Underperform Votes:		551 (Vote Underperform)
Total Votes:		1,033

MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Humana (NYSE:HUM) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	7 Hold Ratings, 13 Buy Ratings
Consensus Rating:	Buy (Score: 2.65)
Consensus Price Target:	$229.50 (2.72% downside)

Analysts' Ratings History for Humana (NYSE:HUM)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
7/14/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$246.00	Low
7/14/2017	Cowen and Company	Reiterated Rating	Buy	$230.00	Low
7/14/2017	Bank of America Corporation	Boost Price Target	Buy	$270.00 -> $275.00	Low
7/13/2017	Credit Suisse Group	Reiterated Rating	Outperform	$245.00 -> $250.00	Low
6/28/2017	Citigroup Inc.	Initiated Coverage	Buy -> Buy	$275.00	Medium
6/23/2017	Cantor Fitzgerald	Reiterated Rating	Not Available -> Neutral		Low
6/9/2017	Argus	Upgrade	Hold -> Buy	$260.00	Low
6/6/2017	Morgan Stanley	Initiated Coverage	Overweight -> Overweight	$262.00	Low
6/5/2017	Royal Bank Of Canada	Reiterated Rating	Hold	$214.00	Low
5/30/2017	Leerink Swann	Boost Price Target	Outperform	$250.00 -> $265.00	Low
5/10/2017	Deutsche Bank AG	Lower Price Target	Hold	$234.00 -> $216.00	Low
5/4/2017	Jefferies Group LLC	Reiterated Rating	Hold	$221.00 -> $230.00	High
4/25/2017	Evercore ISI	Reiterated Rating	Outperform	$240.00	Low
3/30/2017	CIBC	Reiterated Rating	Outperform		Low
3/30/2017	Oppenheimer Holdings Inc.	Initiated Coverage	Outperform -> Outperform	$236.00 -> $236.00	Low
1/24/2017	Stifel Nicolaus	Downgrade	Buy -> Hold	$214.00 -> $210.00	N/A
1/9/2017	Barclays PLC	Reiterated Rating	Hold	$217.00	N/A
12/4/2016	Susquehanna Bancshares Inc	Reiterated Rating	Neutral	$180.00 -> $200.00	N/A
11/10/2016	J P Morgan Chase & Co	Upgrade	Neutral -> Overweight	$163.00 -> $202.00	N/A
7/22/2016	FBR & Co	Lower Price Target	Mkt Perform	$220.00 -> $170.00	N/A
7/21/2016	Wolfe Research	Upgrade	Outperform	$192.00	N/A

(Data available from 7/21/2015 forward)

Earnings History for Humana (NYSE:HUM)

Earnings by Quarter for Humana (NYSE:HUM)

Earnings History by Quarter for Humana (NYSE HUM)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/2/2017
5/3/2017	Q1 2017	$2.55	$2.75	$13.61 billion	$13.76 billion	View	N/A
2/8/2017	Q416	$2.05	$2.09	$13.55 billion	$12.88 billion	View	N/A
11/4/2016	Q316	$3.09	$3.18	$13.41 billion	$13.69 billion	View	N/A
8/3/2016	Q216	$2.23	$2.30	$13.59 billion	$14.00 billion	View	N/A
5/4/2016	Q1	$1.81	$1.86	$13.80 billion	$13.80 billion	View	N/A
2/10/2016	Q415	$1.45	$1.45	$13.51 billion	$13.40 million	View	N/A
11/6/2015	Q315	$2.13	$2.16	$13.64 billion	$13.36 billion	View	N/A
7/29/2015	Q215	$1.63	$1.67	$13.81 billion	$13.73 billion	View	N/A
4/29/2015	Q115	$2.54	$2.47	$13.51 billion	$13.80 billion	View	Listen
2/4/2015	Q414	$1.16	$1.09	$12.41 billion	$12.23 million	View	Listen
11/7/2014	Q314	$2.01	$1.85	$12.34 billion	$12.24 billion	View	Listen
7/30/2014	Q214	$2.19	$2.19	$11.93 billion	$12.22 billion	View	Listen
5/7/2014	Q114	$1.94	$2.35	$11.45 billion	$11.71 billion	View	Listen
2/5/2014	Q413	$0.95	($0.19)	$10.23 billion	$10.20 billion	View	Listen
11/6/2013	Q313	$2.14	$2.31	$10.27 billion	$10.00 billion	View	Listen
7/31/2013	Q2 2013	$2.46	$2.63	$10.36 billion	$10.32 billion	View	Listen
5/1/2013	Q1 2013	$1.80	$2.95	$10.23 billion	$10.49 billion	View	Listen
2/4/2013	Q4 2012	$1.07	$1.19	$9.73 billion	$9.56 billion	View	Listen
11/5/2012	Q312	$2.05	$2.62	$9.86 billion	$9.65 billion	View	N/A
7/30/2012		$2.21	$2.16			View	N/A
4/30/2012		$1.54	$1.49			View	N/A
2/6/2012		$1.20	$1.20			View	N/A
10/31/2011		$2.03	$2.54			View	N/A
8/1/2011		$2.05	$2.50			View	N/A
5/2/2011		$1.86	$1.86			View	N/A
2/7/2011		$0.81	$0.63			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Humana (NYSE:HUM)

2017 EPS Consensus Estimate: $10.69
2018 EPS Consensus Estimate: $13.58

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	4	$2.07	$2.75	$2.36
Q2 2017	4	$2.37	$3.29	$3.00
Q3 2017	4	$3.15	$3.44	$3.26
Q4 2017	4	$1.77	$2.56	$2.08
Q1 2018	1	$2.95	$2.95	$2.95
Q2 2018	1	$3.41	$3.41	$3.41
Q3 2018	1	$3.61	$3.61	$3.61
Q4 2018	1	$3.61	$3.61	$3.61

(Data provided by Zacks Investment Research)

Current Dividend Information for Humana (NYSE:HUM)

Next Dividend:	7/31/2017
Annual Dividend:	$1.60
Dividend Yield:	0.68%
Dividend Growth:	3.10% (3 Year Average)
Payout Ratio:	16.24% (Trailing 12 Months of Earnings) 14.35% (Based on This Year's Estimates) 13.14% (Based on Next Year's Estimates)
Track Record:	6 Years of Consecutive Dividend Growth

Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE HUM)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/20/2017	quarterly	$0.40	0.75%	6/28/2017	6/30/2017	7/31/2017
2/15/2017	quarterly	$0.40	0.78%	3/29/2017	3/31/2017	4/28/2017
10/26/2016	quarterly	$0.29	0.67%	1/10/2017	1/12/2017	1/27/2017
8/25/2016	quarterly	$0.29	0.65%	10/11/2016	10/13/2016	10/28/2016
4/21/2016	quarterly	$0.29	0.66%	6/28/2016	6/30/2016	7/29/2016
2/18/2016	quarterly	$0.29	0.7%	3/29/2016	3/31/2016	4/29/2016
10/29/2015	quarterly	$0.29	0.65%	12/28/2015	12/30/2015	1/29/2016
8/27/2015	quarterly	$0.29	0.63%	9/28/2015	9/30/2015	10/30/2015
4/17/2015	quarterly	$0.29	0.65%	6/26/2015	6/30/2015	7/31/2015
2/18/2015	quarterly	$0.28	0.73%	3/27/2015	3/31/2015	4/24/2015
10/31/2014	quarterly	$0.28	0.81%	12/29/2014	12/31/2014	1/30/2015
8/27/2014	quarterly	$0.28	0.88%	9/26/2014	9/30/2014	10/31/2014
4/30/2014	quarterly	$0.28	1.02%	6/26/2014	6/30/2014	7/25/2014
2/19/2014	quarterly	$0.27	1.06%	3/27/2014	3/31/2014	4/25/2014
10/30/2013	quarterly	$0.27	1.17%	12/27/2013	12/31/2013	1/31/2014
8/22/2013	quarterly	$0.27	1.14%	9/26/2013	9/30/2013	10/25/2013
4/25/2013	quarterly	$0.27	1.47%	6/26/2013	6/28/2013	7/26/2013
2/27/2013	quarterly	$0.26	1.52%	3/26/2013	3/28/2013	4/26/2013

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 99.04%

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Insider Trades by Quarter for Humana (NYSE:HUM)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/28/2017	Brian P Leclaire	SVP	Sell	4,971	$240.00	$1,193,040.00
5/26/2017	Heidi S Margulis	VP	Sell	1,500	$231.96	$347,940.00
5/5/2017	Jody L Bilney	SVP	Sell	4,600	$230.16	$1,058,736.00
5/4/2017	Bruce D Broussard	CEO	Sell	118,231	$225.82	$26,698,924.42
5/4/2017	Timothy S Huval	VP	Sell	13,939	$225.86	$3,148,262.54
3/21/2017	Jody L Bilney	SVP	Sell	4,348	$213.80	$929,602.40
3/6/2017	James E Murray	COO	Sell	31,151	$213.62	$6,654,476.62
3/3/2017	Cynthia H Zipperle	VP	Sell	1,885	$213.37	$402,202.45
2/24/2017	Brian P Leclaire	SVP	Sell	4,971	$204.81	$1,018,110.51
2/22/2017	Brian P Leclaire	SVP	Sell	26,894	$205.24	$5,519,724.56
2/22/2017	James E Murray	COO	Sell	9,523	$204.69	$1,949,262.87
2/22/2017	Roy A Beveridge	VP	Sell	4,832	$205.73	$994,087.36
2/21/2017	Bruce D Broussard	CEO	Sell	104,256	$205.23	$21,396,458.88
2/21/2017	Cynthia H Zipperle	CAO	Sell	4,213	$204.67	$862,274.71
2/21/2017	David A. Jr/Ky Jones	Director	Sell	27,000	$205.04	$5,536,080.00
2/21/2017	James E Murray	COO	Sell	70,332	$205.20	$14,432,126.40
2/21/2017	Jody L Bilney	SVP	Sell	6,087	$204.72	$1,246,130.64
2/21/2017	M Todoroff Christopher	VP	Sell	24,140	$205.33	$4,956,666.20
2/25/2016	Brian P Leclaire	SVP	Sell	183	$176.11	$32,228.13
3/11/2015	James E Murray	COO	Sell	35,220	$160.90	$5,666,898.00
3/2/2015	Brian P Leclaire	SVP	Sell	5,500	$161.79	$889,845.00
2/25/2015	Bruce D Broussard	CEO	Sell	41,105	$165.29	$6,794,245.45
2/25/2015	David A Jr/Ky Jones	Director	Sell	6,100	$165.39	$1,008,879.00
2/24/2015	Heidi S Margulis	VP	Sell	3,665	$164.44	$602,672.60
8/22/2014	Brian P Leclaire	SVP	Sell	3,250	$123.04	$399,880.00
5/15/2014	Heidi Margulis	VP	Sell	3,345	$119.56	$399,928.20
5/12/2014	Marissa Peterson	Director	Sell	2,026	$123.30	$249,805.80
3/19/2014	James Murray	COO	Sell	36,833	$116.59	$4,294,359.47
3/18/2014	M Todoroff Christopher	VP	Sell	8,000	$113.20	$905,600.00
3/13/2014	Bruce Broussard	CEO	Sell	109,000	$109.84	$11,972,560.00
3/10/2014	Webster Roy Dunbar	Director	Sell	9,587	$110.30	$1,057,446.10
12/4/2013	Marissa Peterson	Director	Sell	1,147	$103.54	$118,760.38
12/2/2013	M Todoroff Christopher	VP	Sell	6,000	$105.50	$633,000.00
11/26/2013	Heidi Margulis	VP	Sell	5,500	$104.42	$574,310.00
11/8/2013	David Jr/Ky Jones	Director	Sell	11,000	$95.00	$1,045,000.00
9/5/2013	Elizabeth D Bierbower	Insider	Sell	17,673	$96.01	$1,696,784.73
8/30/2013	Heidi Margulis	VP	Sell	3,319	$93.35	$309,828.65
8/29/2013	David Jr/Ky Jones	Director	Sell	2,500	$93.01	$232,525.00
8/23/2013	Elizabeth Bierbower	Insider	Sell	6,063	$94.00	$569,922.00
8/15/2013	Michael Mccallister	Director	Sell	138,817	$91.49	$12,700,367.33
8/13/2013	Bruce Perkins	Insider	Sell	9,000	$93.47	$841,230.00
8/8/2013	Steven Mcculley	VP	Sell	10,000	$92.54	$925,400.00
8/7/2013	James Bloem	CFO	Sell	33,000	$91.79	$3,029,070.00
8/1/2013	M Todoroff Christopher	VP	Sell	39,596	$90.30	$3,575,518.80
6/24/2013	Paul B K Kusserow	SVP	Sell	34,219	$84.60	$2,894,927.40
6/18/2013	Elizabeth D Bierbower	Insider	Sell	8,033	$83.29	$669,068.57
5/30/2013	James E Murray	COO	Sell	11,000	$81.96	$901,560.00
5/9/2013	Michael B Mccallister	Director	Sell	281,312	$77.72	$21,863,568.64

(Data available from 1/1/2013 forward)

Headline Trends for Humana (NYSE:HUM) Latest Headlines for Humana (NYSE:HUM)

Source:

Date	Headline
	Humana hiring hundreds in Louisville for Medicare Advantage enrollments www.bizjournals.com - July 20 at 11:13 PM
	GOP Obamacare retreat will hit insurers on the tax front finance.yahoo.com - July 18 at 9:57 PM
	Humana Inc. (NYSE:HUM) Price Target Increased to $275.00 by Analysts at Bank of America Corporation www.americanbankingnews.com - July 15 at 7:52 PM
	Humana Inc. (HUM) Receives "Buy" Rating from Piper Jaffray Companies www.americanbankingnews.com - July 15 at 10:16 AM
	Humana's (HUM) Buy Rating Reiterated at Cowen and Company www.americanbankingnews.com - July 15 at 8:14 AM
	Humana Inc. (HUM) Given Consensus Rating of "Buy" by Brokerages www.americanbankingnews.com - July 14 at 11:32 AM
	Humana Inc. (NYSE:HUM) Stock Rating Reaffirmed by Credit Suisse Group www.americanbankingnews.com - July 13 at 8:13 AM
	Humana and Oscar Health Enter Strategic Partnership to Offer ... - Business Wire (press release) www.businesswire.com - July 13 at 2:53 AM
	Humana and Oscar Health Enter Strategic Partnership to Offer Consumer-Focused, Technology-Driven Commercial Small Business Health Insurance, Beginning in Nashville Area finance.yahoo.com - July 13 at 2:52 AM
	Humana And Oscar Partner To Sell Health Plans To Small Businesses finance.yahoo.com - July 13 at 2:52 AM
	$13.64 Billion in Sales Expected for Humana Inc. (NYSE:HUM) This Quarter www.americanbankingnews.com - July 12 at 9:14 AM
	Oscar Health to join Humana in a small business venture www.cnbc.com - July 12 at 7:53 AM
	Humana and Oscar Health inks deal to offer commercial small business health insurance, beginning in Nashville area seekingalpha.com - July 12 at 7:34 AM
	Humana Inc. to Release Second Quarter 2017 Results on August 2, 2017 - Business Wire (press release) www.businesswire.com - July 11 at 5:40 AM
	$3.05 Earnings Per Share Expected for Humana Inc. (HUM) This Quarter www.americanbankingnews.com - July 11 at 12:20 AM
	Humana Inc. to Release Second Quarter 2017 Results on August 2, 2017 finance.yahoo.com - July 10 at 7:36 PM
	Humana hikes pay for board of directors finance.yahoo.com - July 7 at 6:16 AM
	Study of Managed Care Population Suggests Inferior Vena Cava Filters May Be Overused finance.yahoo.com - July 7 at 6:16 AM
	Humana exec sells $4 million in company stock finance.yahoo.com - July 5 at 8:17 PM
	Humana Inc. (HUM) Earns Buy Rating from Analysts at Citigroup Inc. www.americanbankingnews.com - July 2 at 8:08 PM
	Humana subsidiary will expand into KC with 4 primary-care clinics www.bizjournals.com - June 30 at 7:44 PM
	UPDATE 2-Aetna settles on New York for new headquarters in 2018 finance.yahoo.com - June 30 at 7:44 PM
	[$$] Insurers’ Policy Warnings Raise Stakes in Health Fight finance.yahoo.com - June 30 at 7:44 PM
	Aetna settles on New York for new headquarters in 2018 - Reuters www.reuters.com - June 30 at 4:58 AM
	Technical Reports on Healthcare Equities -- UnitedHealth, Humana, Molina Healthcare, and Quorum Health www.bizjournals.com - June 29 at 11:58 PM
	Analyzing WellCare Health Plans (WCG) and Humana (HUM) www.americanbankingnews.com - June 29 at 8:34 PM
	Humana Inc. (HUM) SVP Sells $1,193,040.00 in Stock www.americanbankingnews.com - June 29 at 4:28 PM
	Anthem's Exit Creates Obamacare `Crisis' for Rural Nevadans - Bloomberg www.bloomberg.com - June 29 at 5:15 AM
	Humana Foundation Awards $640000 to Knoxville Nonprofits to Improve Health of Community - Business Wire (press release) www.businesswire.com - June 29 at 12:14 AM
	Humana Foundation Awards $640,000 to Knoxville Nonprofits to Improve Health of Community finance.yahoo.com - June 28 at 7:12 PM
	Don't Expect Failed Humana Deal To Quash Aetna's Desire For M&A finance.yahoo.com - June 28 at 7:12 PM
	Humana Inc. (HUM) Forecasted to Earn FY2018 Earnings of $11.50 Per Share www.americanbankingnews.com - June 26 at 9:18 AM
	Humana out of individual market, with or without Obamacare repeal - Reuters www.reuters.com - June 24 at 6:08 PM
	Humana has a new position — and a new person — in its C-suite www.bizjournals.com - June 23 at 11:05 PM
	CEO Broussard says Humana is out of the individual market, no matter what happens with Obamacare www.bizjournals.com - June 23 at 6:03 PM
	Humana Names Sam Deshpande Chief Risk Officer finance.yahoo.com - June 23 at 6:03 PM
	Here's What to Watch as the Senate Fights Over Healthcare Reform finance.yahoo.com - June 23 at 6:03 PM
	Federal Trade Commission files petition to get court to enforce ... - Memphis Business Journal www.bizjournals.com - June 22 at 6:25 PM
	Humana out of individual market, with or without Obamacare repeal www.cnbc.com - June 22 at 1:23 PM
	Legal update: FTC, Humana file motion re: Walgreens/Rite Aid investigation www.bizjournals.com - June 22 at 1:23 PM
	Humana Inc. (HUM) Upgraded at BidaskClub www.americanbankingnews.com - June 21 at 6:20 PM
	Anthem Blue Cross Blue Shield exits health care exchange marketbeat.com - June 21 at 5:35 PM
	Recipe for Success: Humana Healthier Choices Program Celebrates 10 Years of Improving Health at Taste of Chicago - Business Wire (press release) www.businesswire.com - June 21 at 3:23 PM
	Humana Honored as Silver and Bronze Stevie® Award Winner in 2017 American Business Awards - Business Wire (press release) www.businesswire.com - June 21 at 3:23 PM
	Humana resists FTC subpoena, holding up Walgreens-Rite Aid merger - Louisville Business First www.bizjournals.com - June 21 at 3:23 PM
	Humana resists FTC subpoena, holding up Walgreens-Rite Aid merger finance.yahoo.com - June 21 at 3:23 PM
	Anthem Blue Cross Exits Obamacare In Two More Red States finance.yahoo.com - June 21 at 3:23 PM
	Humana Honored as Silver and Bronze Stevie® Award Winner in 2017 American Business AwardsSM finance.yahoo.com - June 21 at 3:23 PM
	Cigna's 2017 growth may include Medicare Advantage acquisitions finance.yahoo.com - June 21 at 3:23 PM
	Humana Inc. (HUM) Downgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - June 21 at 9:36 AM